“`html

Adenia ‍Partners Expands African Footprint with Parkville Pharmaceuticals Acquisition

cairo, Egypt – January 27, 2026 – Africa-focused⁤ private equity‍ firm Adenia Partners ⁣has finalized an agreement to acquire a majority stake in Parkville ⁢Pharmaceuticals, marking its first majority investment ⁢within Egypt’s rapidly growing healthcare sector. The deal signifies⁢ a growing trend of private equity investment in North African⁣ pharmaceutical companies.

Transaction Details

The stake was acquired from Admaius Capital Partners, alongside Parkville’s⁢ Chairman Dr.Sherif Bassiouny and co-founder and CEO Dr. Mahmoud⁣ Farrag. While the financial ‍terms of‍ the ⁤transaction remain confidential, it represents a significant investment in a key regional player. The acquisition is subject to standard⁤ regulatory approvals.

About parkville Pharmaceuticals

Founded in 2008 and headquartered in Cairo,Parkville pharmaceuticals has established itself as a ⁢prominent manufacturer ‍and⁢ distributor of pharmaceutical,cosmeceutical,and nutraceutical products. The company’s diverse portfolio includes offerings in skincare, haircare, deodorants, wellness products, and therapeutic medicines.⁢ Parkville distinguishes itself through a commitment to in-house research and advancement, stringent manufacturing quality control, and a robust⁣ distribution network across Egypt and neighboring markets.

Adenia’s Strategic Rationale

Adenia Partners views Parkville Pharmaceuticals as a platform for growth within the‍ broader African ⁢healthcare landscape.The investment will be strategically deployed to support ‍several key initiatives, including:

• Product ⁣Portfolio Expansion: Introducing new and innovative products to‍ meet evolving‍ consumer needs.
• Digital Transformation: Accelerating the development of digital and e-commerce channels to enhance market reach ⁢and ‍customer engagement.
• Regional Expansion: entering new markets within the Middle East ⁢and Africa to capitalize⁢ on growing demand for affordable,high-quality healthcare products.

“We are delighted that our first acquisition in Egypt is into⁣ one of the region’s fastest-growing ⁢healthcare businesses,” stated Stéphane Bacquaert,Managing Partner at Adenia Partners. “We see strong potential in Parkville’s affordable,high-quality health and ⁢personal care offering.”‍ adenia Partners focuses on backing scalable, locally built businesses‍ across the ‍African continent.

Heba Hakky,Principal at ⁤Adenia Partners,added ⁢that the transaction underscores confidence ⁢in Egypt’s long-term economic stability and the ⁤potential of local ⁢companies to achieve regional ⁣prominence.

Parkville’s Future Outlook

Mahmoud Farrag, CEO of Parkville Pharmaceuticals, expressed⁢ enthusiasm for the partnership with Adenia. “